The Manufacture Data

Illumina Boosts Assay for Faster Tumor Profiling

Illumina Launches Next-Generation TruSight Oncology 500 v2 to Broaden Access to Comprehensive Tumor Profiling Illumina Inc., a global leader in DNA sequencing and array-based technologies, has unveiled the next-generation version of its flagship cancer research assay—TruSight Oncology 500 version 2…